Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SON DNA binding protein (SON) is a large, multifunctional nuclear protein that serves as a critical scaffold for nuclear speckles and a co-factor for pre-mRNA splicing. It is particularly essential for the efficient splicing of transcripts with weak or suboptimal splice sites, many of which encode proteins involved in cell cycle progression, DNA repair, and centrosome assembly. Beyond its role in RNA processing, SON acts as a transcriptional repressor, notably for the hepatitis B virus core promoter, and regulates hematopoietic stem cell fate. In clinical contexts, heterozygous loss-of-function mutations in the SON gene cause Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, a rare multisystem developmental disorder characterized by intellectual disability and brain malformations. Conversely, SON is often overexpressed in various cancers, including pancreatic cancer and leukemia, where it promotes cell survival and tumorigenicity, making it a potential therapeutic target. Recent research has also identified small molecules like pyrvinium pamoate that interact with SON to modulate nuclear speckle dynamics, offering a potential strategy for treating proteinopathies such as Alzheimer's disease.
Modulation of nuclear speckle dynamics and protein quality control via interaction with the intrinsically disordered region of SON; inhibition of oncogenic splicing and cell cycle progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SON DNA binding protein (SON) (SON).